hiPSC Models
The Choroideremia Research Foundation (CRF) has created an internationally accessible BioBank to provide key cellular resources for CHM research. These resources, housed at WiCell and Coriell, allow scientists to study the disease at a microscopic level.
Using induced pluripotent stem cells (iPSCs) derived from CHM patients, researchers can:
- Study disease progression in human cells.
- Test potential treatments on human cells rather than relying solely on animal models, which may not respond the same way.
Access CHM BioBank resources:
CRF is registered as a US 501(c)3 nonprofit organization EIN: 04-3511754
Our mission is to raise funds in support of scientific research leading to a treatment or cure of choroideremia, a hereditary retinal-degenerative disease that causes blindness; to educate people affected by the disease; and to inform the public.
©Copyright 2025 The Choroideremia Research Foundation Inc. All Rights Reserved.